Skip to main content
Toggle navigation
Login
Search
Home
Full Schedule
Home
Full Schedule
All Days
Fri, Mar 31
Sat, Apr 1
Thu, Apr 20
Fri, Apr 21
Fri, May 19
Sat, May 20
Thu, Jun 15
Fri, Jun 16
Fri, Jul 21
Sat, Jul 22
Thu, Aug 17
Fri, Aug 18
Thu, Sep 14
Fri, Sep 15
Full Schedule
Type here to filter the list
Saturday, May 20, 2023
8:00 AM – 8:15 AM
.
Session IV
8:00 AM – 8:15 AM
.
Welcome
8:15 AM – 9:00 AM
.
Session IV: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
8:15 AM – 9:00 AM
.
Session IV: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
8:15 AM – 8:45 AM
.
Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
8:45 AM – 9:00 AM
.
Q&A Panel
9:15 AM – 10:30 AM
.
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Alan C. Moss, MD, FACG, AGAF, FRCPI
– Boston University & Boston Medical Center
9:15 AM – 10:30 AM
.
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Alan C. Moss, MD, FACG, AGAF, FRCPI
– Boston University & Boston Medical Center
9:15 AM – 9:35 AM
.
Small But Mighty: JAK Inhibitors
Speaker:
Alan C. Moss, MD, FACG, AGAF, FRCPI
– Boston University & Boston Medical Center
9:35 AM – 9:55 AM
.
'Old' But True: Anti-TNF and Anti-Integrins
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
9:55 AM – 10:15 AM
.
The 'New' Wave: Anti-Interleukins Are Here
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
10:15 AM – 10:30 AM
.
Q&A Panel
10:30 AM – 11:00 AM
.
Exhibit Hall Break
10:30 AM – 11:00 AM
.
Exhibit Hall Break
11:00 AM – 12:00 PM
.
Non-CME Innovation Theater: Is It Time To Rethink Your Approach With Your Moderate UC Patients?
11:00 AM – 12:00 PM
.
Non-CME Innovation Theater: Is It Time To Rethink Your Approach With Your Moderate UC Patients?
12:15 PM – 1:00 PM
.
Session VI: Special Situations in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
12:15 PM – 1:00 PM
.
Session VI: Special Situations in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
12:15 PM – 12:30 PM
.
Pregnancy in IBD
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
12:30 PM – 12:45 PM
.
Perioperative Management of IBD
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
12:45 PM – 1:00 PM
.
Q&A Panel
1:00 PM – 1:45 PM
.
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
1:00 PM – 1:45 PM
.
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
1:00 PM – 1:30 PM
.
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
1:00 PM – 1:45 PM
.
Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
1:30 PM – 1:45 PM
.
Q&A Panel
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater: Case by Case
2:00 PM – 3:00 PM
.
Non-CME Innovation Theater: Case by Case
3:15 PM – 4:00 PM
.
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:15 PM – 4:00 PM
.
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:15 PM – 3:45 PM
.
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM – 4:00 PM
.
Q&A Panel
4:00 PM – 4:45 PM
.
Session IX: Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM
.
Session IX: Putting your knowledge to the test: Challenging IBD cases
4:00 PM – 4:45 PM
.
Case Panel